Clay Roscoe

Dr. Roscoe was appointed to Sedia's Executive Team as Chief Medical Officer of Sedia in January 2021 and has worked for Sedia since Nobember 2018 as Medical Advisor. He is board-certified in Family Medicine and has worked as an HIV clinical specialist for over 15 years. Dr. Roscoe provides general medical advice and guidance on the diagnosis and treatment of persons living with HIV, including in the setting of PEPFAR-supported programs in Africa. He also assists with the identification of new market opportunities, provides sales force support and contributes to ongoing Sedia research projects. He has worked in Namibia, Southern Africa, both for the University of Washington Department of Global Health (ITECH) and the U.S. Centers for Disease Control and Prevention. Dr. Roscoe has extensive clinical and public health research experience in HIV and tuberculosis, as well as more recently in public health preparedness for and diagnosis of SARS-CoV-2. Dr. Roscoe is a faculty physician at the Family Medicine Residency of Idaho and an Assistant Clinical Professor at the University of Washington School of Medicine. Based in Boise, Idaho, he also is the Medical Director for Idaho Southwest District Health, a district level public health department. Dr. Roscoe received his medical degree from the Perelman School of Medicine at the University of Pennsylvania, holds a Master’s in Science in Public Health from the London School of Hygiene and Tropical Medicine, and a B.S. and B.A. from Gonzaga University.